# PDP-26: [Public Benefit Funding] The Bridge Career Fellowship

- Space: [PsyDAO](https://snapshot.box/s:psydao.eth.md)
- Author: 0x46bD2DCb47B87ddE8c3977e4C810EeB83d9Ef785
- State: Rejected
- Voting type: Basic
- Start: 2026-07-10 09:18 UTC
- End: 2026-07-14 09:18 UTC
- Votes: 10
- Quorum: 1,023,341.55 voting power
- Discussion: https://discord.com/channels/898139202594668585/1521217984389976134
- Open in Snapshot: https://snapshot.box/#/s:psydao.eth/proposal/0x0706edb32f7a719dbc0839495ee774ee3e53bb761fce9dc52256f677a0a411a8

## Results

- For: 1,312,630.16 voting power, 18.5%
- Against: 5,782,292.73 voting power, 81.5%
- Abstain: 0 voting power, 0.0%

## Proposal

### Requested Funding: £27,000 (~$36,000)
**Project Owner:** Aleksandra Wingert (MSc), PhD Candidate, Imperial College London (@olawin.)

## Summary:
Six months of bridging support for a post-PhD researcher to complete and submit several microdosing papers that would otherwise go unpublished, giving the public a clearer and more honest account of what microdosing does, and to lay the groundwork for a new study on endometriosis and apply for the funding to run it.

The Self-Blinding Citizen Science Microdosing Study 2.0 enrolled 42 people with symptoms of anxiety and depression who either took a microdose or a placebo for four weeks. Several important analyses sit outside the PhD thesis and will not be finished in time for it: the task-based and resting-state EEG brain recordings, a paper on sleep changes and HRV, a prospective paper on microdosing, and a female-specific hormonal patterns analysis. Without dedicated time, these are unlikely to be completed for years, if ever. Finishing them would move the public picture of microdosing from scattered and uncertain to genuinely conclusive: a realistic, harm-reduction-focused account that answers the hype with evidence.

The proposal also seeds something new. The early groundwork for an independent endometriosis study — a focused literature review, scoping, and survey design — is the kind of work that centralised institutions are not likely to pay for, because they fund finished study designs, not the preparation that makes a study fundable. That is the gap public benefit funding exists to fill. Endometriosis and women's health are one of the most neglected areas of medical research, and no scoping study exists in relation to psychedelics.

This is a one-time grant with no recurring ask. The six months produce a fellowship application and a scoped, de-risked study, so PsyDAO seeds a project that then attracts independent support. PsyDAO's role is to catalyse, not to keep funding. Open-access papers and all scoping and survey materials will be shared openly, with PsyDAO named as funder.

View the Google Doc to see the full proposal, including the project's impact, milestones, financial details, and risk assessment: https://docs.google.com/document/d/1-7O26UZw8e74O87HkgNfleimhAf6X9di/edit?usp=sharing&ouid=118397740210508375837&rtpof=true&sd=true

---

To vote or create proposals from an AI assistant, connect the Snapshot MCP at https://mcp.snapshot.box

